TY - BOOK PY - 2018 DA - 2018// TI - British National Formulary (BNF) 75 (March 2018) PB - BMJ Publishing Group Ltd and Royal Pharmaceutical Society CY - London ID - ref1 ER - TY - JOUR PY - 2016 DA - 2016// TI - Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31678-6 DO - 10.1016/S0140-6736(16)31678-6 ID - ref2 ER - TY - JOUR PY - 2016 DA - 2016// TI - Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31012-1 DO - 10.1016/S0140-6736(16)31012-1 ID - ref3 ER - TY - JOUR AU - Bramness, J. G. AU - Mann, K. AU - Wurst, F. M. PY - 2016 DA - 2016// TI - Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders: a survey among European Federation of Addiction Societies in Europe JO - Eur Addict Res. VL - 22 UR - https://doi.org/10.1159/000447965 DO - 10.1159/000447965 ID - Bramness2016 ER - TY - JOUR AU - Thompson, A. AU - Ashcroft, D. M. AU - Owens, L. AU - Staa, T. P. AU - Pirmohamed, M. PY - 2017 DA - 2017// TI - Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study JO - PLoS One. VL - 12 UR - https://doi.org/10.1371/journal.pone.0173272 DO - 10.1371/journal.pone.0173272 ID - Thompson2017 ER - TY - JOUR AU - Witkiewitz, K. AU - Vowles, K. E. PY - 2018 DA - 2018// TI - Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review JO - Alcohol Clin Exp Res. VL - 42 UR - https://doi.org/10.1111/acer.13594 DO - 10.1111/acer.13594 ID - Witkiewitz2018 ER - TY - JOUR AU - Jayaram-Lindström, N. AU - Hammarberg, A. AU - Beck, O. AU - Franck, J. PY - 2008 DA - 2008// TI - Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial JO - Am J Psychiatry. VL - 165 UR - https://doi.org/10.1176/appi.ajp.2008.08020304 DO - 10.1176/appi.ajp.2008.08020304 ID - Jayaram-Lindström2008 ER - TY - JOUR AU - Kampman, K. AU - Pettinati, H. AU - Lynch, K. AU - Plebani, J. AU - Lachewitz, J. AU - Feeney, K. PY - 2015 DA - 2015// TI - Modafinil and naltrexone for the treatment of comorbid cocaine and alcohol dependence JO - Drug Alcohol Depend. VL - 146 UR - https://doi.org/10.1016/j.drugalcdep.2014.09.331 DO - 10.1016/j.drugalcdep.2014.09.331 ID - Kampman2015 ER - TY - JOUR AU - Grant, J. E. AU - Kim, S. W. PY - 2008 DA - 2008// TI - Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges JO - J Clin Psychiatry. VL - 69 UR - https://doi.org/10.4088/JCP.v69n0511 DO - 10.4088/JCP.v69n0511 ID - Grant2008 ER - TY - JOUR AU - Grant, J. E. AU - Kim, S. W. PY - 2009 DA - 2009// TI - Odlaug BL. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania JO - Biol Psychiatry. VL - 65 UR - https://doi.org/10.1016/j.biopsych.2008.11.022 DO - 10.1016/j.biopsych.2008.11.022 ID - Grant2009 ER - TY - JOUR AU - Papay, K. AU - Xie, S. X. AU - Stern, M. AU - Hurtig, H. AU - Siderowf, A. AU - Duda, J. E. PY - 2014 DA - 2014// TI - Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study JO - Neurology. VL - 83 UR - https://doi.org/10.1212/WNL.0000000000000729 DO - 10.1212/WNL.0000000000000729 ID - Papay2014 ER - TY - JOUR AU - O’Malley, S. S. AU - Sinha, R. AU - Grilo, C. M. AU - Capone, C. AU - Farren, C. K. AU - McKee, S. A. PY - 2007 DA - 2007// TI - Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial JO - Alcohol Clin Exp Res. VL - 31 ID - O’Malley2007 ER - TY - JOUR AU - Roy, A. AU - Roy, M. AU - Deb, S. AU - Unwin, G. AU - Roy, A. PY - 2015 DA - 2015// TI - Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review JO - J Intellect Disabil Res. VL - 59 UR - https://doi.org/10.1111/jir.12122 DO - 10.1111/jir.12122 ID - Roy2015 ER - TY - JOUR AU - Zagon, I. S. AU - McLaughlin, P. J. PY - 1984 DA - 1984// TI - Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer JO - Life Sci. VL - 35 UR - https://doi.org/10.1016/0024-3205(84)90651-9 DO - 10.1016/0024-3205(84)90651-9 ID - Zagon1984 ER - TY - JOUR AU - Yi, Z. AU - Guo, S. AU - Hu, X. AU - Wang, X. AU - Zhang, X. AU - Griffin, N. PY - 2016 DA - 2016// TI - Functional modulation on macrophage by low dose naltrexone (LDN) JO - Int Immunopharmacol. VL - 39 UR - https://doi.org/10.1016/j.intimp.2016.08.015 DO - 10.1016/j.intimp.2016.08.015 ID - Yi2016 ER - TY - JOUR AU - Cree, B. A. C. AU - Kornyeyeva, E. AU - Goodin, D. S. PY - 2010 DA - 2010// TI - Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis JO - Ann Neurol. VL - 68 ID - Cree2010 ER - TY - JOUR AU - Traore, A. K. AU - Thiero, O. AU - Dao, S. AU - Kounde, F. F. C. AU - Cisse, M. AU - Mccandless, J. B. PY - 2011 DA - 2011// TI - Impact of low dose naltrexone (LDN) on antiretroviral therapy (ART) treated HIV + adults in Mali: a single blind randomized clinical trial JO - J AIDS HIV Res. VL - 3 ID - Traore2011 ER - TY - JOUR AU - Smith, J. P. AU - Bingaman, S. I. AU - Ruggiero, F. AU - Mauger, D. T. AU - Mukherjee, A. AU - McGovern, C. O. PY - 2011 DA - 2011// TI - Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn’s disease: a randomized placebo-controlled trial JO - Dig Dis Sci. VL - 56 UR - https://doi.org/10.1007/s10620-011-1653-7 DO - 10.1007/s10620-011-1653-7 ID - Smith2011 ER - TY - JOUR AU - Younger, J. AU - Noor, N. AU - McCue, R. AU - MacKey, S. PY - 2013 DA - 2013// TI - Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels JO - Arthritis Rheum. VL - 65 UR - https://doi.org/10.1002/art.37734 DO - 10.1002/art.37734 ID - Younger2013 ER - TY - JOUR AU - Sturn, K. M. AU - Collin, M. PY - 2016 DA - 2016// TI - Low-dose naltrexone: a new therapy option for complex regional pain syndrome type I patients JO - Int J Pharm Compd. VL - 20 ID - Sturn2016 ER - TY - JOUR AU - Weinstock, L. B. AU - Myers, T. L. AU - Shetty, A. PY - 2017 DA - 2017// TI - Low-dose naltrexone for the treatment of sarcoidosis JO - Sarcoidosis Vasc Diffuse Lung Dis. VL - 34 ID - Weinstock2017 ER - TY - JOUR AU - Cao, S. AU - Lilly, E. AU - Chen, S. T. PY - 2018 DA - 2018// TI - Variable response to naltrexone in patients with Hailey-Hailey disease JO - JAMA Dermatology. VL - 154 UR - https://doi.org/10.1001/jamadermatol.2017.5463 DO - 10.1001/jamadermatol.2017.5463 ID - Cao2018 ER - TY - BOOK PY - 2017 DA - 2017// TI - announces exclusive agreement for sale of lodonal in Kenya valued at over $31 million ID - ref23 ER - TY - JOUR AU - Raknes, G. AU - Småbrekke, L. PY - 2017 DA - 2017// TI - A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study JO - Pharmacoepidemiol Drug Saf. VL - 26 UR - https://doi.org/10.1002/pds.4110 DO - 10.1002/pds.4110 ID - Raknes2017 ER - TY - JOUR AU - Raknes, G. AU - Simonsen, P. AU - Småbrekke, L. PY - 2018 DA - 2018// TI - The effect of low dose naltrexone on medication in inflammatory bowel disease: a quasi experimental before-and-after prescription database study JO - J Crohns Colitis. VL - 12 UR - https://doi.org/10.1093/ecco-jcc/jjy008 DO - 10.1093/ecco-jcc/jjy008 ID - Raknes2018 ER - TY - STD TI - House of Commons. House of Commons Deb (29 Jun 2009, vol. 495, col. 88W–89W) https://publications.parliament.uk/pa/cm200809/cmhansrd/chan101.pdf. Accessed 12 Dec 2018 UR - https://publications.parliament.uk/pa/cm200809/cmhansrd/chan101.pdf ID - ref26 ER - TY - STD TI - U.S. Food and Drug Administration. Safety Information - Revia (naltrexone HCl) tablets: safety labeling changes approved by FDA Centre for Drug Evaluation and Research (CDER). MedWatch Safety Information. U.S.: Department of Health and Human Services; 2013. https://wayback.archive-it.org/7993/20161023084600/http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm374896.htm. Accessed 7 Oct 2017 UR - https://wayback.archive-it.org/7993/20161023084600/http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm374896.htm ID - ref27 ER - TY - JOUR AU - Pfohl, D. N. AU - Allen, J. I. AU - Atkinson, R. L. R. L. AU - Knopman, D. S. AU - Malcolm, R. J. AU - Mitchell, J. E. PY - 1986 DA - 1986// TI - Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage JO - NIDA Res Monogr. VL - 67 ID - Pfohl1986 ER - TY - JOUR AU - Croop, R. S. AU - Faulkner, E. B. AU - Labriola, D. F. PY - 1997 DA - 1997// TI - for the Naltrexone Usage Study Group. The safety profile of naltrexone in the treatment of alcoholism. Results from a multicentre usage study. The Naltrexone Usage Study Group JO - Arch Gen Psychiatry. VL - 54 UR - https://doi.org/10.1001/archpsyc.1997.01830240090013 DO - 10.1001/archpsyc.1997.01830240090013 ID - Croop1997 ER - TY - JOUR AU - Brewer, C. AU - Wong, V. S. PY - 2004 DA - 2004// TI - Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature JO - Addict Biol. VL - 9 UR - https://doi.org/10.1080/13556210410001674130 DO - 10.1080/13556210410001674130 ID - Brewer2004 ER - TY - JOUR AU - Ioannidis, J. P. AU - Lau, J. PY - 2001 DA - 2001// TI - Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas JO - JAMA. VL - 285 UR - https://doi.org/10.1001/jama.285.4.437 DO - 10.1001/jama.285.4.437 ID - Ioannidis2001 ER - TY - JOUR AU - Loke, Y. K. AU - Derry, S. PY - 2001 DA - 2001// TI - Reporting of adverse drug reactions in randomised controlled trials - a systematic survey JO - BMC Clin Pharmacol. VL - 1 UR - https://doi.org/10.1186/1472-6904-1-3 DO - 10.1186/1472-6904-1-3 ID - Loke2001 ER - TY - JOUR AU - Ioannidis, J. P. A. AU - Evans, S. J. W. AU - Gøtzsche, P. C. AU - O’Neill, R. T. AU - Altman, D. G. AU - Schulz, K. PY - 2004 DA - 2004// TI - Better reporting of harms in randomized trials: an extension of the CONSORT statement JO - Ann Intern Med. VL - 141 UR - https://doi.org/10.7326/0003-4819-141-10-200411160-00009 DO - 10.7326/0003-4819-141-10-200411160-00009 ID - Ioannidis2004 ER - TY - JOUR AU - Zorzela, L. AU - Loke, Y. K. AU - Ioannidis, J. P. AU - Golder, S. AU - Santaguida, P. AU - Altman, D. G. PY - 2016 DA - 2016// TI - PRISMA harms checklist: improving harms reporting in systematic reviews JO - BMJ. VL - i157 ID - Zorzela2016 ER - TY - JOUR PY - 2012 DA - 2012// TI - Commission Guideline - Guidance on posting and publication of result-related information on clinical trials in relation to the implementation of Article 57(2) of Regulation (EC) No 726/2004 and Article 41(2) of Regulation (EC) No 1901/2006 JO - J Eur Union VL - C302 ID - ref35 ER - TY - JOUR AU - Zarin, D. A. AU - Tse, T. AU - Williams, R. J. AU - Carr, S. PY - 2016 DA - 2016// TI - Special report. Trial reporting in ClinicalTrials.gov – the final rule JO - N Engl J Med. VL - 375 UR - https://doi.org/10.1056/NEJMsr1611785 DO - 10.1056/NEJMsr1611785 ID - Zarin2016 ER - TY - JOUR AU - Sinclair, J. M. A. AU - Chambers, S. E. AU - Shiles, C. J. AU - Baldwin, D. S. PY - 2016 DA - 2016// TI - Safety and tolerability of pharmacological treatment of alcohol dependence: comprehensive review of evidence JO - Drug Saf. VL - 39 UR - https://doi.org/10.1007/s40264-016-0416-y DO - 10.1007/s40264-016-0416-y ID - Sinclair2016 ER - TY - JOUR AU - Patten, D. K. AU - Schultz, B. G. AU - Berlau, D. J. PY - 2018 DA - 2018// TI - The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn’s disease, and other chronic pain disorders JO - Pharmacotherapy VL - 38 UR - https://doi.org/10.1002/phar.2086 DO - 10.1002/phar.2086 ID - Patten2018 ER - TY - JOUR AU - Johnson, R. A. AU - Lukens, J. M. AU - Kole, J. W. AU - Sisti, D. A. PY - 2015 DA - 2015// TI - Views about responsibility for alcohol addiction and negative evaluations of naltrexone JO - Subst Abuse Treat Prev Policy. VL - 10 UR - https://doi.org/10.1186/s13011-015-0004-7 DO - 10.1186/s13011-015-0004-7 ID - Johnson2015 ER - TY - JOUR AU - Brown, S. -. E. AU - Vagenas, P. AU - Konda, K. A. AU - Clark, J. L. AU - Lama, J. R. AU - Gonzales, P. PY - 2017 DA - 2017// TI - Men who have sex with men in Peru: acceptability of medication-assisted therapy for treating alcohol use disorders JO - Am J Mens Health. VL - 11 UR - https://doi.org/10.1177/1557988315576775 DO - 10.1177/1557988315576775 ID - Brown2017 ER - TY - JOUR AU - Yen, M. H. AU - Ko, H. C. AU - Tang, F. I. AU - Lu, R. B. AU - Hong, J. S. PY - 2006 DA - 2006// TI - Study of hepatotoxicity of naltrexone in the treatment of alcoholism JO - Alcohol. VL - 38 UR - https://doi.org/10.1016/j.alcohol.2006.05.003 DO - 10.1016/j.alcohol.2006.05.003 ID - Yen2006 ER - TY - JOUR AU - McDonough, M. PY - 2015 DA - 2015// TI - Naltrexone and liver disease JO - Aust Prescr. VL - 38 ID - McDonough2015 ER - TY - JOUR AU - Crowley, P. PY - 2015 DA - 2015// TI - Author’s response JO - Aust Prescr. VL - 38 UR - https://doi.org/10.18773/austprescr.2015.015 DO - 10.18773/austprescr.2015.015 ID - Crowley2015 ER - TY - JOUR AU - McPherson, K. AU - Hemminki, E. PY - 2004 DA - 2004// TI - Synthesising licensing data to assess drug safety JO - BMJ. VL - 328 UR - https://doi.org/10.1136/bmj.328.7438.518 DO - 10.1136/bmj.328.7438.518 ID - McPherson2004 ER - TY - BOOK AU - Dalton, D. AU - Williams, N. PY - 2014 DA - 2014// TI - Building a culture of candour: a review of the threshold for the duty of candour and of the incentives for care organisations to be candid PB - Royal College of Surgeons of England CY - London ID - Dalton2014 ER - TY - STD TI - Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). Chichester: Wiley; 2011. http://handbook.cochrane.org UR - http://handbook.cochrane.org ID - ref46 ER - TY - BOOK PY - 2006 DA - 2006// TI - EudraLex volume 10: Clinical trials. EudraLex PB - Publications Office of the European Union CY - Luxembourg ID - ref47 ER - TY - JOUR PY - 2011 DA - 2011// TI - Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use (“CT-3”) JO - J Eur Union VL - C172 ID - ref48 ER - TY - BOOK PY - 2012 DA - 2012// TI - Safety reporting requirements for INDs and BA/BE studies PB - FDA CY - Silver Springs ID - ref49 ER - TY - BOOK AU - Harmonised Tripartite Guideline, I. C. H. PY - 1994 DA - 1994// TI - Clinical safety data management: definitions and standards for expedited reporting E2A PB - ICH CY - Geneva ID - Harmonised Tripartite Guideline1994 ER - TY - JOUR AU - Loke, Y. K. AU - Price, D. AU - Herxheimer, A. PY - 2007 DA - 2007// TI - Systematic reviews of adverse effects: framework for a structured approach JO - BMC Med Res Methodol. VL - 7 UR - https://doi.org/10.1186/1471-2288-7-32 DO - 10.1186/1471-2288-7-32 ID - Loke2007 ER - TY - STD TI - Loke YK, Price D, Herxheimer A. Chapter 14: Adverse effects. In: Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5. London: The Cochrane Collaboration; 2011. http://handbook.cochrane.org. UR - http://handbook.cochrane.org ID - ref52 ER - TY - JOUR AU - Derry, S. AU - Loke, Y. K. AU - Aronson, J. K. PY - 2001 DA - 2001// TI - Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials JO - BMC Med Res Methodol. VL - 1 UR - https://doi.org/10.1186/1471-2288-1-7 DO - 10.1186/1471-2288-1-7 ID - Derry2001 ER - TY - STD TI - Higgins J, Altman D, Sterne JAC, editors. Chapter 8: Assessing risk of bias in included studies. In: Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5. London: The Cochrane Collaboration; 2011. http://handbook.cochrane.org UR - http://handbook.cochrane.org ID - ref54 ER - TY - STD TI - Deeks J, Higgins J, Altman D, (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5. London: The Cochrane Collaboration; 2011. http://handbook.cochrane.org. UR - http://handbook.cochrane.org ID - ref55 ER - TY - JOUR AU - Sweeting, M. J. AU - Sutton, A. J. AU - Lambert, P. C. PY - 2004 DA - 2004// TI - What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data JO - Stat Med. VL - 23 UR - https://doi.org/10.1002/sim.1761 DO - 10.1002/sim.1761 ID - Sweeting2004 ER - TY - JOUR AU - Diamond, G. A. AU - Bax, L. AU - Kaul, S. PY - 2007 DA - 2007// TI - Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death JO - Ann Intern Med. VL - 147 UR - https://doi.org/10.7326/0003-4819-147-8-200710160-00182 DO - 10.7326/0003-4819-147-8-200710160-00182 ID - Diamond2007 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - the PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - Ann Intern Med. VL - 151 UR - https://doi.org/10.7326/0003-4819-151-4-200908180-00135 DO - 10.7326/0003-4819-151-4-200908180-00135 ID - Moher2009 ER - TY - JOUR AU - Papanikolaou, P. N. AU - Ioannidis, J. P. A. PY - 2004 DA - 2004// TI - Availability of large-scale evidence on specific harms from systematic reviews of randomized trials JO - Am J Med. VL - 117 UR - https://doi.org/10.1016/j.amjmed.2004.04.026 DO - 10.1016/j.amjmed.2004.04.026 ID - Papanikolaou2004 ER - TY - JOUR AU - Rothwell, P. M. PY - 2005 DA - 2005// TI - External validity of randomised controlled trials: “to whom do the results of this trial apply?” JO - Lancet. VL - 365 UR - https://doi.org/10.1016/S0140-6736(04)17670-8 DO - 10.1016/S0140-6736(04)17670-8 ID - Rothwell2005 ER - TY - JOUR AU - Kirkham, J. J. AU - Dwan, K. M. AU - Altman, D. G. AU - Gamble, C. AU - Dodd, S. AU - Smyth, R. PY - 2010 DA - 2010// TI - The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews JO - BMJ. VL - 340 UR - https://doi.org/10.1136/bmj.c365 DO - 10.1136/bmj.c365 ID - Kirkham2010 ER - TY - JOUR AU - Becker, J. E. AU - Krumholz, H. M. AU - Ben-Josef, G. AU - Ross, J. S. PY - 2014 DA - 2014// TI - Reporting of results in clinicaltrials.gov and high-impact journals JO - JAMA. VL - 311 UR - https://doi.org/10.1001/jama.2013.285634 DO - 10.1001/jama.2013.285634 ID - Becker2014 ER - TY - JOUR AU - Jonas, D. E. AU - Amick, H. R. AU - Feltner, C. AU - Bobashev, G. AU - Thomas, K. AU - Wines, R. PY - 2014 DA - 2014// TI - Pharmacotherapy for adults with alcohol use disorders in outpatient settings JO - JAMA. VL - 311 UR - https://doi.org/10.1001/jama.2014.3628 DO - 10.1001/jama.2014.3628 ID - Jonas2014 ER - TY - JOUR AU - Spagnolo, P. A. AU - Colloca, L. AU - Heilig, M. PY - 2015 DA - 2015// TI - The role of expectation in the therapeutic outcomes of alcohol and drug addiction treatments JO - Alcohol Alcohol. VL - 50 UR - https://doi.org/10.1093/alcalc/agv015 DO - 10.1093/alcalc/agv015 ID - Spagnolo2015 ER - TY - JOUR AU - Page, M. J. AU - McKenzie, J. E. AU - Kirkham, J. AU - Dwan, K. AU - Kramer, S. AU - Green, S. PY - 2014 DA - 2014// TI - Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions JO - Cochrane Database Syst Rev. VL - 10 ID - Page2014 ER - TY - JOUR AU - Rösner, S. AU - Hackl-Herrwerth, A. AU - Leucht, S. AU - Vecchi, S. AU - Srisurapanont, M. AU - Soyka, M. PY - 2010 DA - 2010// TI - Opioid antagonists for alcohol dependence JO - Cochrane Database Syst Rev. VL - 12 ID - Rösner2010 ER - TY - BOOK AU - Pryce, R. AU - Buykx, P. AU - Gray, L. AU - Stone, T. AU - Drummond, C. AU - Brennan, A. PY - 2017 DA - 2017// TI - Estimates of alcohol dependence in England based on APMS 2014, including estimates of children living in a household with an adult with alcohol dependence. Prevalence, trends and amenability to treatment PB - Public Health England CY - London ID - Pryce2017 ER - TY - JOUR AU - Walters, D. AU - Connor, J. P. AU - Feeney, G. F. X. AU - Young, R. M. PY - 2009 DA - 2009// TI - The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence JO - J Addict Dis. VL - 28 UR - https://doi.org/10.1080/10550880902772456 DO - 10.1080/10550880902772456 ID - Walters2009 ER - TY - JOUR AU - Dunlap, L. J. AU - Zarkin, G. A. AU - Bray, J. W. AU - Mills, M. AU - Kivlahan, D. R. AU - McKay, J. R. PY - 2010 DA - 2010// TI - Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective JO - Med Care. VL - 48 UR - https://doi.org/10.1097/MLR.0b013e3181ca3d40 DO - 10.1097/MLR.0b013e3181ca3d40 ID - Dunlap2010 ER - TY - JOUR AU - Rehm, J. AU - Shield, K. D. AU - Gmel, G. AU - Rehm, M. X. AU - Frick, U. PY - 2013 DA - 2013// TI - Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union JO - Eur Neuropsychopharmacol. VL - 23 UR - https://doi.org/10.1016/j.euroneuro.2012.08.001 DO - 10.1016/j.euroneuro.2012.08.001 ID - Rehm2013 ER - TY - JOUR AU - Hodkinson, A. AU - Kirkham, J. J. AU - Tudur-Smith, C. AU - Gamble, C. PY - 2013 DA - 2013// TI - Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension JO - BMJ Open. VL - 3 UR - https://doi.org/10.1136/bmjopen-2013-003436 DO - 10.1136/bmjopen-2013-003436 ID - Hodkinson2013 ER - TY - JOUR AU - Afsharimani, B. AU - Doornebal, C. W. AU - Cabot, P. J. AU - Hollmann, M. W. AU - Parat, M. O. PY - 2015 DA - 2015// TI - Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis JO - Br J Pharmacol. VL - 172 UR - https://doi.org/10.1111/bph.12589 DO - 10.1111/bph.12589 ID - Afsharimani2015 ER - TY - JOUR AU - Budzyński, J. AU - Rybakowski, J. AU - Swiatkowski, M. AU - Torliński, L. AU - Kłopocka, M. AU - Kosmowski, W. PY - 2000 DA - 2000// TI - Naltrexone exerts a favourable effect on plasma lipids in abstinent patients with alcohol dependence JO - Alcohol Alcohol. VL - 35 UR - https://doi.org/10.1093/alcalc/35.1.91 DO - 10.1093/alcalc/35.1.91 ID - Budzyński2000 ER -